Prostate Cancer Early Detection, Version 1.2014
Peter R. Carroll(University of California, San Francisco), Maria Ho, Paul Maroni(University of Colorado Cancer Center), Andrew J. Vickers(Memorial Sloan Kettering Cancer Center), Todd M. Morgan(University of Michigan), George P. Hemstreet(University of Oklahoma), J. Kellogg Parsons(University of San Diego), Robert Wake(St. Jude Children's Research Hospital), Jonathan I. Epstein(Johns Hopkins University), William J. Catàlona(Northwestern University), Daniel A. Barocas(Vanderbilt University Medical Center), James L. Mohler, Veda N. Giri(Yale Cancer Center), Dorothy A. Shead(University of the Witwatersrand), Gerald L. Andriole(Institut thématique Génétique, génomique et bioinformatique), Michael Poch(Moffitt Cancer Center), John W. Davis(The University of Texas MD Anderson Cancer Center), Chuck Scales(Cancer Institute (WIA)), Robert B. Nadler(Northwestern University), Paul H. Lange(Fred Hutch Cancer Center), Robert R. Bahnson(Fox Chase Cancer Center), Kevin R. Loughlin(Brigham and Women's Hospital), Mark H. Kawachi(City of Hope), Terrence M. Shanefelt(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), William T. Lowrance(University of Utah), Douglas M. Dahl(Harvard University)
Cited by 107
Related Papers
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
|Nature Genetics|2007|1.1k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996